Profile
Ajay Madan served as Vice President-Preclinical Development at Neurocrine Biosciences, Inc. from 2013 to 2016.
Prior to that, he was Chief Scientific Officer at XenoTech LLC in 2001-2002.
Currently, he is Vice President-Development at Crinetics Pharmaceuticals, Inc. since 2016.
Dr. Madan received his undergraduate degree from Birla Institute of Technology & Science and his doctorate from the University of Kansas.
Former positions of Ajay Madan
| Companies | Position | End |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/03/2022 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 30/06/2016 |
XenoTech LLC
XenoTech LLC BiotechnologyHealth Technology Provides drug metabolism and drug interaction studies in preclinical/nonclinical drug development | Corporate Officer/Principal | 31/12/2001 |
Training of Ajay Madan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Birla Institute of Technology & Science
Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoTech LLC
XenoTech LLC BiotechnologyHealth Technology Provides drug metabolism and drug interaction studies in preclinical/nonclinical drug development | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
- Stock Market
- Insiders
- Ajay Madan
















